https://www.thelistededge.ca/p/intellia-therapeutics-ntla-a-highThe Listed Edgeen2026-10-07T06:15:43+00:00Intellia Therapeutics (NTLA): A High-Risk Bet on the Commercialization of CRISPR Gene Editing